Hi-Fi Biotech India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-12-2024
- Paid Up Capital ₹ 2.50 M
as on 24-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 24-12-2024
- Revenue 10.77%
(FY 2020)
- Profit 339.26%
(FY 2020)
- Ebitda 29.39%
(FY 2020)
- Net Worth 47.48%
(FY 2020)
- Total Assets 22.97%
(FY 2020)
About Hi-Fi Biotech India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹3.00 M.
Meiazhagan Subramanian and Palanimuthu Boopathi serve as directors at the Company.
- CIN/LLPIN
U01403TZ2013PTC019488
- Company No.
019488
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Hi-Fi Biotech India Private Limited offer?
Hi-Fi Biotech India Private Limited offers a wide range of products and services, including Tropical Fruits, Pineapple, Fresh Flowers, Plants & Trees, Natural Flowers, Plant Tissue Culture, Tissue Cultured Plant, Bananas.
Who are the key members and board of directors at Hi-Fi Biotech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palanimuthu Boopathi  | Managing Director | 15-May-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meiazhagan Subramanian | Director | 06-Jun-2014 | Current |
Financial Performance of Hi-Fi Biotech India.
Hi-Fi Biotech India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 10.77% increase. The company also saw a substantial improvement in profitability, with a 339.26% increase in profit. The company's net worth Soared by an impressive increase of 47.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hi-Fi Biotech India?
In 2017, Hi-Fi Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunfiield Agrow Tech Private LimitedActive 16 years 7 monthsMeiazhagan Subramanian is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2022 | ₹0.50 M | Open |
Others Creation Date: 14 Apr 2016 | ₹2.50 M | Open |
How Many Employees Work at Hi-Fi Biotech India?
Unlock and access historical data on people associated with Hi-Fi Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hi-Fi Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi-Fi Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
